13 terminated. 13 Phase 2, 3 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 13 | Terminated 13 |
| Phase 3 | 3 | Terminated 3 |
| Phase 1 | 1 | Terminated 1 |
Follow Apnea: new trials by email Literature Review of Apnea trials Research Report on Apnea
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Danavorexton in People With Obstructive Sleep Apnea After General Anesthesia for Abdominal Surgery Danavorexton, Placebo - Sleep Apnea | Phase 2 | Terminated | Takeda | 41 | 2023-05-11 | 2025-09-16 |
| Metabolic Effects of Metformin Therapy in Obstructive Sleep Apnea Metformin + PAP, Placebo oral capsule + PAP - Sleep Apnea, Obstructive | Phase 1 / Phase 2 | Terminated | Pennington Biomedical Research Center | 16 | 2021-01-28 | 2023-01-19 |
| Validation of Sleep Apnea Screening Device Phase II Obstructive Sleep Apnea Screening Device - Obstructive Sleep Apnea | Phase 2 | Terminated | University of Michigan | 30 | 2017-11-14 | 2023-01-27 |
| Intraoperative Low-dose Ketamine Infusion for Patients With Obstructive Sleep Apnea Ketamine, Control - Sleep Apnea, Obstructive Sleep Apnea | Phase 2 / Phase 3 | Terminated | University of Alabama at Birmingham | 9 | 2016-06-02 | 2019-12-19 |
| OneShot Renal Denervation Registry OneShot Ablation System - Hypertension, Heart Failure | Phase 2 / Phase 3 | Terminated | Medtronic Endovascular | 51 | 2014-07-01 | 2015-09-02 |
| Efficacy of AerosalĀ® in the Treatment of Sub-Obstructive Adenotonsillar Hypertrophy and Related Diseases Halotherapy, Placebo - Sleep Apnea, Obstructive | Phase 2 | Terminated | Tecno Sun SRL | 45 | 2012-02-01 | 2012-11-08 |
| Inhalation of Low Concentration of CO2 in Preterm Infants Not Responding to Caffeine for the Treatment of Apnea Inhalation of low concentration of CO2 - Apnea of Prematurity | Phase 2 / Phase 3 | Terminated | University of Manitoba | 7 | 2011-10-01 | 2015-02-19 |
| Evaluation of the Effect of AVE0657 in Cheynes-Stokes Breathing Syndrome Patients AVE0657, placebo - Heart Failure, Sleep Apnea Syndromes | Phase 2 | Terminated | Sanofi | 8 | 2008-06-01 | 2009-05-01 |
| Systemic Inflammation and Obstructive Sleep Apnea Syndrome: Effect of Atorvastatin Atorvastatin treatment, CPAP device, sham CPAP treatment - Obstructive Sleep Apnea Syndrome | Phase 2 | Terminated | University Hospital, Grenoble | 54 | 2008-05-01 | 2013-09-24 |
| Treatment of Refractory Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnea/Hypopnea Syndrome (OSA/HS) Using Nasal Continuous Positive Airway Pressure (nCPAP) Therapy (0249-015) Comparator: MK0249, Comparator: placebo, Comparator: modafinil - Sleep Apnea, Obstructive, Hypopnea Syndrome | Phase 2 | Terminated | Merck Sharp & Dohme LLC | 125 | 2008-02-01 | 2015-05-13 |
| A Trial of Infant Flow Biphasic Nasal Continuous Airway Pressure (NCPAP) Versus Infant Flow NCPAP for the Facilitation of Extubation in Infants </= 1250 Grams Biphasic Infant flow NCPAP, CPAP - Infant, Premature, Diseases, Bronchopulmonary Dysplasia | Phase 2 | Terminated | Mount Sinai Hospital, Canada | 136 | 2006-04-01 | 2009-05-05 |
| Effect of Fenofibrate on Sleep Apnea Syndrome Placebo, Fenofibrate - Dyslipidemia, Sleep Apnea Syndrome | Phase 2 | Terminated | Solvay Pharmaceuticals | 34 | 2005-09-01 | 2009-07-22 |
| Sleep Apnea Treatment After Stroke (SATS) continuous positive airway pressure or CPAP, sham CPAP - Obstructive Sleep Apnea, Stroke | Phase 2 | Terminated | University of Michigan | 32 | 2004-09-01 | 2013-03-11 |
Sleep Apnea, Obstructive (8) · Sleep Apnea Syndromes (6) · Heart Failure (2) · Bronchopulmonary Dysplasia (1) · Cheyne-Stokes Respiration (1) · Diabetes Mellitus (1) · Disorders of Excessive Somnolence (1) · Dyslipidemias (1) · Hypertension (1) · Infant, Premature, Diseases (1) · Obesity (1) · Overweight (1) · Postoperative Complications (1) · Stroke (1)
Respiration Disorders (13) · Respiratory Tract Diseases (13) · Dyssomnias (11) · Nervous System Diseases (11) · Sleep Disorders, Intrinsic (11) · Sleep Wake Disorders (11) · Pathological Conditions, Signs and Symptoms (5) · Sleep Apnea Syndromes (5) · Signs and Symptoms (4) · Cardiovascular Diseases (3) · Signs and Symptoms, Respiratory (3) · Heart Diseases (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2)
Continuous Positive Airway Pressure (1) · Fenofibrate (1) · Hydroxymethylglutaryl-CoA Reductase Inhibitors (1) · Ketamine (1) · Metformin (1) · TAK-925 (1)
University of Michigan (2) · Medtronic Endovascular (1) · Merck Sharp & Dohme LLC (1) · Mount Sinai Hospital, Canada (1) · Pennington Biomedical Research Center (1) · Sanofi (1) · Solvay Pharmaceuticals (1) · Takeda (1) · Tecno Sun SRL (1) · University Hospital, Grenoble (1) · University of Alabama at Birmingham (1) · University of Manitoba (1)
United States (5) · France (3) · Canada (2) · Italy (2) · Germany (1) · Spain (1) · Switzerland (1)
Devin Brown, MD, MS (1) · Jack Kalbfleisch, PhD (1) · Karel O'Brien, MB, FRCPC (1) · Lewis Morgenstern, MD (1) · Matteo Gelardi, MD (1) · Peter A Nagi, MD (1) · Prachi Singh, PhD (1) · Ruben E Alvaro, MD (1)
PMID 20297950, PMID 21784661, PMID 22475409, PMID 23920422, PMID 24041858, PMID 25221387, PMID 26567858, PMID 38346816
2005 (1), P30DK072476 (1)